Antonio G. V.
- Country
- Spain
- Department
- Dermatology
Research Overview
- Efficacy and Safety of Lebrikizumab in Adults With Nummular Dermatitis Inadequately Controlled by Topical Corticosteroids: A Phase 3, Randomized, Placebo-Controlled Study
- A Randomized, Blinded, Placebo Controlled, Phase 2a Proof-of-Concept Study to Evaluate Efficacy, Safety, and Tolerability of GS-5718 in Participants with Cutaneous Lupus Erythematosus (CLE)
- Evaluation of Lebrikizumab Efficacy and Safety in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Phase 3 Randomized Study
Data & Insights
Has run more than one trial at 33 of 168 partner sites.
Specializations
Inflammatory Skin Disease
Clinical research activity is concentrated in dermatology with a strong focus on chronic inflammatory skin disorders, especially hidradenitis suppurativa, atopic dermatitis, nummular dermatitis, and cutaneous lupus erythematosus. The trial portfolio also includes treatment options for severe, relapsing disease and symptom control in difficult-to-manage cutaneous conditions.
- Hidradenitis suppurativa
- Atopic dermatitis
- Cutaneous lupus erythematosus
- Nummular dermatitis
Therapeutic interests include targeted immunomodulatory therapy, JAK inhibition, and topical anti-inflammatory treatment for persistent skin inflammation.
Allergic Airway and Ocular Disease
Another area of involvement is allergic rhinoconjunctivitis linked to house dust mite sensitization, alongside acute asthma management in children and patients with reactive airway symptoms. This reflects a therapeutic interest in allergy-driven respiratory and ocular disease.
- Allergic rhinoconjunctivitis
- House dust mite allergy
- Acute asthma
Research activity in this domain includes allergen immunotherapy and bronchodilator-based treatment for acute and persistent allergic disease.
Pulmonary and Chronic Respiratory Disorders
The investigator is also involved in studies of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease, indicating interest in progressive respiratory conditions with limited therapeutic options. These studies address both fibrotic lung disease and exacerbation-prone obstructive airway disease.
- Idiopathic pulmonary fibrosis
- Chronic obstructive pulmonary disease
Therapeutic focus includes anti-fibrotic treatment and exacerbation prevention in chronic lung disease.
Immune-Mediated Gastroenterology and Oncology Supportive Care
Research involvement extends to ulcerative colitis and to a surgical oncology setting involving prevention of esophagojejunal anastomotic dehiscence after gastrectomy for cancer. This broadens the clinical landscape toward inflammatory bowel disease and postoperative complication reduction.
- Ulcerative colitis
- Esophagojejunal anastomotic dehiscence
Therapeutic interest includes advanced biologic therapy for intestinal inflammation and fibrin-based adhesive strategies in surgical care.
Urologic and Breast Cancer Therapy
The clinical portfolio also includes non-muscle invasive bladder cancer and HR-positive, HER2-negative early breast cancer, showing participation in oncology-focused therapeutic development across distinct tumor types.
- Non-muscle invasive bladder cancer
- HR-positive/HER2-negative early breast cancer
Key areas of interest include bladder cancer immunotherapy and adjuvant endocrine-based treatment in early breast cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.